249 related articles for article (PubMed ID: 1417380)
1. Transdermal clonidine reduced some withdrawal symptoms but did not increase smoking cessation.
Prochazka AV; Petty TL; Nett L; Silvers GW; Sachs DP; Rennard SI; Daughton DM; Grimm RH; Heim C
Arch Intern Med; 1992 Oct; 152(10):2065-9. PubMed ID: 1417380
[TBL] [Abstract][Full Text] [Related]
2. Effects of transdermal clonidine treatment on withdrawal symptoms associated with smoking cessation. A randomized, controlled trial.
Ornish SA; Zisook S; McAdams LA
Arch Intern Med; 1988 Sep; 148(9):2027-31. PubMed ID: 3046542
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial of nortriptyline combined with transdermal nicotine for smoking cessation.
Prochazka AV; Kick S; Steinbrunn C; Miyoshi T; Fryer GE
Arch Intern Med; 2004 Nov; 164(20):2229-33. PubMed ID: 15534159
[TBL] [Abstract][Full Text] [Related]
4. [Effects of transdermal nicotine as an adjunct in smoking cessation therapy. A double-blind randomized study controlled with placebo].
Daughton DM; Heatley SA; Prendergast JJ; Causey D; Knowles M; Rolf CN; Cheney RA; Hatlelid K; Thompson AB; De Blasio F
Arch Monaldi Mal Torace; 1992; 47(1-6):17-29. PubMed ID: 1306633
[TBL] [Abstract][Full Text] [Related]
5. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
Shiffman S
Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
[TBL] [Abstract][Full Text] [Related]
6. [Effect of transdermal therapy with clonidine on suppression symptoms secondary to smoking cessation].
Cervantes Escárcega JL; Guadalajara Boo JF
Arch Inst Cardiol Mex; 1992; 62(5):435-40. PubMed ID: 1482222
[TBL] [Abstract][Full Text] [Related]
7. Effect of pre-treatment with nicotine patch on withdrawal symptoms and abstinence rates in smokers subsequently quitting with the nicotine patch: a randomized controlled trial.
Schuurmans MM; Diacon AH; van Biljon X; Bolliger CT
Addiction; 2004 May; 99(5):634-40. PubMed ID: 15078238
[TBL] [Abstract][Full Text] [Related]
8. Prediction of abstinence at 10 weeks based on smoking status at 2 weeks during a quit attempt: secondary analysis of two parallel, 10-week, randomized, double-blind, placebo-controlled clinical trials of 21-mg nicotine patch in adult smokers.
Ferguson SG; Gitchell JG; Shiffman S; Sembower MA
Clin Ther; 2009 Sep; 31(9):1957-65. PubMed ID: 19843485
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction.
Moolchan ET; Robinson ML; Ernst M; Cadet JL; Pickworth WB; Heishman SJ; Schroeder JR
Pediatrics; 2005 Apr; 115(4):e407-14. PubMed ID: 15805342
[TBL] [Abstract][Full Text] [Related]
10. Nicotine patch therapy in adolescent smokers.
Smith TA; House RF; Croghan IT; Gauvin TR; Colligan RC; Offord KP; Gomez-Dahl LC; Hurt RD
Pediatrics; 1996 Oct; 98(4 Pt 1):659-67. PubMed ID: 8885942
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of a 16-hour transdermal nicotine patch in a medical practice setting, without intensive group counseling.
Sachs DP; Säwe U; Leischow SJ
Arch Intern Med; 1993 Aug; 153(16):1881-90. PubMed ID: 8110249
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of buspirone in smoking cessation: a placebo-controlled trial.
Schneider NG; Olmstead RE; Steinberg C; Sloan K; Daims RM; Brown HV
Clin Pharmacol Ther; 1996 Nov; 60(5):568-75. PubMed ID: 8941030
[TBL] [Abstract][Full Text] [Related]
13. Nicotine replacement therapy for patients with coronary artery disease. Working Group for the Study of Transdermal Nicotine in Patients with Coronary artery disease.
Arch Intern Med; 1994 May; 154(9):989-95. PubMed ID: 8179456
[TBL] [Abstract][Full Text] [Related]
14. Nicotine patches and the subjective effects of cigarette smoking: a pilot study.
Cárdenas L; Busto UE; MacDonald A; Corrigall WA
Can J Clin Pharmacol; 2002; 9(4):175-82. PubMed ID: 12584575
[TBL] [Abstract][Full Text] [Related]
15. Clonidine for smoking cessation.
Nana A; Praditsuwan R
J Med Assoc Thai; 1998 Feb; 81(2):87-93. PubMed ID: 9529836
[TBL] [Abstract][Full Text] [Related]
16. The nicotine patch in smoking cessation. A randomized trial with telephone counseling.
Westman EC; Levin ED; Rose JE
Arch Intern Med; 1993 Aug; 153(16):1917-23. PubMed ID: 8250653
[TBL] [Abstract][Full Text] [Related]
17. Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal.
Teneggi V; Tiffany ST; Squassante L; Milleri S; Ziviani L; Bye A
Psychopharmacology (Berl); 2002 Nov; 164(2):177-87. PubMed ID: 12404080
[TBL] [Abstract][Full Text] [Related]
18. Combined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trial.
Kornitzer M; Boutsen M; Dramaix M; Thijs J; Gustavsson G
Prev Med; 1995 Jan; 24(1):41-7. PubMed ID: 7740014
[TBL] [Abstract][Full Text] [Related]
19. A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation.
O'Malley SS; Cooney JL; Krishnan-Sarin S; Dubin JA; McKee SA; Cooney NL; Blakeslee A; Meandzija B; Romano-Dahlgard D; Wu R; Makuch R; Jatlow P
Arch Intern Med; 2006 Mar; 166(6):667-74. PubMed ID: 16567607
[TBL] [Abstract][Full Text] [Related]
20. Which smokers are helped to give up smoking using transdermal nicotine patches? Results from a randomized, double-blind, placebo-controlled trial.
Yudkin PL; Jones L; Lancaster T; Fowler GH
Br J Gen Pract; 1996 Mar; 46(404):145-8. PubMed ID: 8731618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
